220 related articles for article (PubMed ID: 6086700)
41. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
42. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
Yanase T; Sekiya K; Ando M; Nawata H; Kato K; Ibayashi H
Acta Endocrinol (Copenh); 1985 Sep; 110(1):36-41. PubMed ID: 2994336
[TBL] [Abstract][Full Text] [Related]
43. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
[TBL] [Abstract][Full Text] [Related]
44. Urinary levels of immunoreactive NH2-terminal of pro-opiomelanocortin in patients with malignant pulmonary disease.
Gaspar L; Gilbert F; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1989 Aug; 12(4):241-6. PubMed ID: 2535437
[TBL] [Abstract][Full Text] [Related]
45. Loperamide, an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease.
Bochicchio D; Ambrosi B; Faglia G
Neuroendocrinology; 1988 Dec; 48(6):611-4. PubMed ID: 2855105
[TBL] [Abstract][Full Text] [Related]
46. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
47. Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary.
Proulx-Ferland L; Labrie F; Dumont D; Côté J; Coy DH; Sveiraf J
Science; 1982 Jul; 217(4554):62-3. PubMed ID: 6283632
[TBL] [Abstract][Full Text] [Related]
48. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum.
Okamoto E; Takagi T; Makino T; Sata H; Iwata I; Nishino E; Mitsuda N; Sugita N; Otsuki Y; Tanizawa O
Horm Metab Res; 1989 Oct; 21(10):566-72. PubMed ID: 2553573
[TBL] [Abstract][Full Text] [Related]
49. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
[TBL] [Abstract][Full Text] [Related]
50. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W
J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280
[TBL] [Abstract][Full Text] [Related]
51. Effects of immunoneutralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocorticotropin.
Carnes M; Lent SJ; Goodman B; Mueller C; Saydoff J; Erisman S
Endocrinology; 1990 Apr; 126(4):1904-13. PubMed ID: 2156671
[TBL] [Abstract][Full Text] [Related]
52. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
[TBL] [Abstract][Full Text] [Related]
53. Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary.
Usategui R; Oliver C; Vaudry H; Lombardi G; Rozenberg I; Mourre AM
Endocrinology; 1976 Jan; 98(1):189-96. PubMed ID: 174889
[TBL] [Abstract][Full Text] [Related]
54. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation.
Aguilera G; Lightman SL; Kiss A
Endocrinology; 1993 Jan; 132(1):241-8. PubMed ID: 8380375
[TBL] [Abstract][Full Text] [Related]
55. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
[TBL] [Abstract][Full Text] [Related]
56. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
[TBL] [Abstract][Full Text] [Related]
57. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay.
Crosby SR; Stewart MF; Ratcliffe JG; White A
J Clin Endocrinol Metab; 1988 Dec; 67(6):1272-7. PubMed ID: 2848055
[TBL] [Abstract][Full Text] [Related]
58. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
[TBL] [Abstract][Full Text] [Related]
59. Effect of prolonged administration of CRF on plasma concentrations of ACTH in patients with Addison's disease.
Pirich K; Vierhapper H; Nowotny P; Waldhäusl W
Exp Clin Endocrinol; 1986 Jul; 87(2):208-10. PubMed ID: 3019743
[TBL] [Abstract][Full Text] [Related]
60. Ovine corticotropin-releasing hormone stimulation test in normal children.
Ross JL; Schulte HM; Gallucci WT; Cutler GB; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1986 Feb; 62(2):390-2. PubMed ID: 3001126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
